Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Down 52.9% in July

Key Points

• Nihon Kohden Corporation experienced a significant decline in short interest, dropping by 52.9% to 3,200 shares in July.
• The company reported a net margin of 5.77% and earnings of $0.01 per share for the latest quarter, with revenues of $346.24 million.
• Nihon Kohden's share price fell 6.6% to $11.18, and its market capitalization now stands at $1.91 billion.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totaling 3,200 shares, adropof52.9% from the July 15th total of 6,800 shares. Approximately0.0% of the shares of the stock are short sold. Based on an average daily volume of 8,900 shares, the short-interest ratio is presently 0.4 days. Based on an average daily volume of 8,900 shares, the short-interest ratio is presently 0.4 days. Approximately0.0% of the shares of the stock are short sold.

Nihon Kohden Trading Down 6.6%

Shares of OTCMKTS:NHNKY traded down $0.79 during trading on Friday, reaching $11.18. The company's stock had a trading volume of 13,297 shares, compared to its average volume of 3,576. Nihon Kohden has a 12 month low of $9.86 and a 12 month high of $17.28. The firm's 50 day simple moving average is $12.08 and its two-hundred day simple moving average is $13.00. The stock has a market capitalization of $1.91 billion, a PE ratio of 20.70 and a beta of 0.34.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. The firm had revenue of $346.24 million during the quarter. Nihon Kohden had a net margin of 5.77% and a return on equity of 6.80%.

Nihon Kohden Company Profile

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.